Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.

导出 OA

翻译打印收藏纠错

作者： Venkatrao,Vantaku ^[1] ; Sri Ramya,Donepudi ^[2] ; Danthasinghe Waduge Badrajee,Piyarathna ^[1] ; Chandra Sekhar,Amara ^[1] ; Chandrashekar R,Ambati ^[2] ; Wei,Tang ^[3] ; Vasanta,Putluri ^[2] ; Darshan S,Chandrashekar ^[4] ; Sooryanarayana,Varambally ^[4] ; Martha K,Terris ^[5] ; Kimberly,Davies ^[5] ; Stefan,Ambs ^[3] ; Roni,Bollag ^[5] ; Andrea B,Apolo ^[6] ; Arun,Sreekumar ^[1] ; Nagireddy,Putluri ^[7]

作者单位： Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, Texas. ^[1] Dan L. Duncan Cancer Center, Advanced Technology Core, Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, Texas. ^[2] Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. ^[3] Department of Pathology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama. ^[4] Augusta University, Augusta, Georgia. ^[5] Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. ^[6] Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas. ^[7]

关键词 bladder cancer liquid chromatography-mass spectrometry (LC-MS)metabolomics racial disparity serum